Skip Navigation LinksHome > Published Ahead-of-Print > Soluble biomarkers of HIV transmission, disease progression...
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0b013e32835c7134
REVIEW: PDF Only

Soluble biomarkers of HIV transmission, disease progression and comorbidities.

Leeansyah, Edwin; Malone, David F.G.; Anthony, Donald D.; Sandberg, Johan K.

Published Ahead-of-Print
Collapse Box

Abstract

Purpose of review: The purpose of this study is to survey and synthesize recent progress in soluble biomarkers relevant to HIV-1 disease stages, progression and comorbidities.

Recent findings: Soluble biomarkers in plasma and other body fluids provide insight into many aspects of HIV-1 disease. Chemokines and defensins in breast milk and cervicovaginal secretions have been associated with HIV-1 susceptibility and transmission. Acute infection plasma cytokine storm components, including serum amyloid A, IFN[gamma]-induced protein 10, interleukin (IL)-12, interferon-gamma (IFN[gamma]), IL-7 and IL-15, may help predict viral load set-point and the subsequent disease progression. During chronic infection, IL-6, soluble (s)CD14, sCD163, high-sensitivity C-reactive protein, D-dimer, fibrin and hyaluronic acid can help predict comorbidities, and to some extent disease progression and mortality, in patients both on and off antiretroviral therapy. Furthermore, recent results suggest that assessment of combinations of soluble biomarkers may prove more powerful than the single factors alone in predicting disease.

Summary: Soluble biomarkers help us understand HIV-1 immunopathogenesis. Integration of many biomarkers derived from a single plasma sample might become a powerful tool to optimize and individualize treatment and care.

(C) 2013 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.